lactic acid has been researched along with gw9662 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izawa, Y; Suzuki, N; Takahashi, S | 1 |
| Egashira, K; Kim-Mitsuyama, S; Matoba, T; Nagahama, R; Nakano, K; Sunagawa, K | 1 |
2 other study(ies) available for lactic acid and gw9662
| Article | Year |
|---|---|
Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia.
Topics: Analysis of Variance; Anilides; Animals; Astrocytes; Benzophenones; Cell Shape; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Energy Metabolism; Hypoglycemic Agents; Lactic Acid; Neurons; Pioglitazone; PPAR gamma; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiazolidinediones; Tyrosine | 2009 |
Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Topics: Anilides; Animals; Fibroblast Growth Factor 1; Hindlimb; Humans; Injections, Intramuscular; Ischemia; Lactic Acid; Mice; Mice, Knockout; Models, Animal; Nanoparticles; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphorylation; Pioglitazone; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; PPAR gamma; Regional Blood Flow; Thiazolidinediones; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor B | 2012 |